MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. - Mukherjee N; Skees J; Todd KJ; West DA; Lambert KA; Robinson WA; Amato CM; Couts KL; Van Gulick R; MacBeth M; Nassar K; Tan AC; et al. (Cell death & disease, 2020)